3-Year Update from the Epcore NHL-1 Trial: Epcoritamab Leads to Deep and Durable Responses in Relapsed or Refractory Large B-Cell Lymphoma

Julie M. Vose; Chan Y. Cheah; Michael Roost Clausen; David Cunningham; Umar Farooq; Tatyana Feldman; Herve Ghesquieres; Wojciech Jurczak; Kim Linton; Catherine Thieblemont; Tycel J. Phillips; Won Seog Kim; Pegah Jafarinasabian; Barbara D'Angelo Mansson; David Soong; Andrew J. Steele; Zhu Li; Christian Eskelund; Martin Hutchings; Yasmin H. Karimi

doi:10.1182/blood-2024-198714

3-Year Update from the Epcore NHL-1 Trial: Epcoritamab Leads to Deep and Durable Responses in Relapsed or Refractory Large B-Cell Lymphoma

Julie M. Vose
, Chan Y. Cheah
, Michael Roost Clausen
, David Cunningham
, Umar Farooq
, Tatyana Feldman
, Herve Ghesquieres
, Wojciech Jurczak
, Kim Linton
, Catherine Thieblemont
, Tycel J. Phillips
, Won Seog Kim
, Pegah Jafarinasabian
, Barbara D'Angelo Mansson
, David Soong
, Andrew J. Steele
, Zhu Li
, Christian Eskelund
, Martin Hutchings
, Yasmin H. Karimi

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	4480
Pages (from-to)	4480-4482
Number of pages	3
Journal	Blood
Volume	144
Issue number	S1
DOIs	https://doi.org/10.1182/blood-2024-198714
Publication status	Published - 5 Nov 2024
Event	66th ASH Annual Meeting & Exposition - San Diego, United States Duration: 7 Dec 2024 → 10 Dec 2024 https://www.hematology.org/meetings/annual-meeting/schedule-and-program

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1182/blood-2024-198714

Cite this

Vose, J. M., Cheah, C. Y., Clausen, M. R., Cunningham, D., Farooq, U., Feldman, T., Ghesquieres, H., Jurczak, W., Linton, K., Thieblemont, C., Phillips, T. J., Kim, W. S., Jafarinasabian, P., Mansson, B. DA., Soong, D., Steele, A. J., Li, Z., Eskelund, C., Hutchings, M., & Karimi, Y. H. (2024). 3-Year Update from the Epcore NHL-1 Trial: Epcoritamab Leads to Deep and Durable Responses in Relapsed or Refractory Large B-Cell Lymphoma. Blood, 144(S1), 4480-4482. Article 4480. https://doi.org/10.1182/blood-2024-198714

@article{a70d58bd4ae54e62b29eec35b29ac1f3,

title = "3-Year Update from the Epcore NHL-1 Trial: Epcoritamab Leads to Deep and Durable Responses in Relapsed or Refractory Large B-Cell Lymphoma",

author = "Vose, \{Julie M.\} and Cheah, \{Chan Y.\} and Clausen, \{Michael Roost\} and David Cunningham and Umar Farooq and Tatyana Feldman and Herve Ghesquieres and Wojciech Jurczak and Kim Linton and Catherine Thieblemont and Phillips, \{Tycel J.\} and Kim, \{Won Seog\} and Pegah Jafarinasabian and Mansson, \{Barbara D'Angelo\} and David Soong and Steele, \{Andrew J.\} and Zhu Li and Christian Eskelund and Martin Hutchings and Karimi, \{Yasmin H.\}",

year = "2024",

month = nov,

day = "5",

doi = "10.1182/blood-2024-198714",

language = "English",

volume = "144",

pages = "4480--4482",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier BV",

number = "S1",

note = "66th ASH Annual Meeting \& Exposition ; Conference date: 07-12-2024 Through 10-12-2024",

url = "https://www.hematology.org/meetings/annual-meeting/schedule-and-program",

}

Vose, JM, Cheah, CY, Clausen, MR, Cunningham, D, Farooq, U, Feldman, T, Ghesquieres, H, Jurczak, W, Linton, K, Thieblemont, C, Phillips, TJ, Kim, WS, Jafarinasabian, P, Mansson, BDA, Soong, D, Steele, AJ, Li, Z, Eskelund, C, Hutchings, M & Karimi, YH 2024, '3-Year Update from the Epcore NHL-1 Trial: Epcoritamab Leads to Deep and Durable Responses in Relapsed or Refractory Large B-Cell Lymphoma', Blood, vol. 144, no. S1, 4480, pp. 4480-4482. https://doi.org/10.1182/blood-2024-198714

TY - JOUR

T1 - 3-Year Update from the Epcore NHL-1 Trial

T2 - 66th ASH Annual Meeting & Exposition

AU - Vose, Julie M.

AU - Cheah, Chan Y.

AU - Clausen, Michael Roost

AU - Cunningham, David

AU - Farooq, Umar

AU - Feldman, Tatyana

AU - Ghesquieres, Herve

AU - Jurczak, Wojciech

AU - Linton, Kim

AU - Thieblemont, Catherine

AU - Phillips, Tycel J.

AU - Kim, Won Seog

AU - Jafarinasabian, Pegah

AU - Mansson, Barbara D'Angelo

AU - Soong, David

AU - Steele, Andrew J.

AU - Li, Zhu

AU - Eskelund, Christian

AU - Hutchings, Martin

AU - Karimi, Yasmin H.

PY - 2024/11/5

Y1 - 2024/11/5

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:001411188300022&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1182/blood-2024-198714

DO - 10.1182/blood-2024-198714

M3 - Meeting Abstract

SN - 0006-4971

VL - 144

SP - 4480

EP - 4482

JO - Blood

JF - Blood

IS - S1

M1 - 4480

Y2 - 7 December 2024 through 10 December 2024

ER -

3-Year Update from the Epcore NHL-1 Trial: Epcoritamab Leads to Deep and Durable Responses in Relapsed or Refractory Large B-Cell Lymphoma

UN SDGs

Access to Document

Other files and links

Cite this